Tvardi Therapeutics
Price & Volume
Stats
See more52W Range | $8.13-$34.31 |
Market Cap | $242.2M |
Shares Short | 594,235 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • last month
Tvardi Therapeutics director Shaheen Wirk resigns from board
Yahoo Finance • last month
Cantor Fitzgerald initiates coverage on Tvardi Therapeutics stock with Overweight rating
Yahoo Finance • 3 months ago
Tvardi Therapeutics files to sell 2.08M shares of common stock for holders
About
CEO | Dr. Imran Alibhai Ph.D. |
Address | 3 Sugar Creek Center Boulevard, Sugar Land, TX, United States, 77478 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
